Increases local manufacturing and export capacity
LAVAL, QC, June 10, 2016 /CNW/ - Valeant Canada today announced that it is further expanding its Canadian manufacturing and export capacity with an investment of $7 million into its Steinbach, Manitoba manufacturing plant. This follows an $8 million announcement earlier this week, for the transfer of two new technologies to Steinbach's manufacturing facility.
Today's announcement includes new measures that will involve modernization of the plant through the upgrading of product manufacturing technology to ensure the robust security of our products through international distribution channels.
These investments will ensure compliance with US regulatory requirements and maintain the Steinbach plant's North American manufacturing mandates. It currently exports 75% of its production, generating $1.6 billion annually in export value.
"We are proud of the investments made in the Steinbach manufacturing plant. Beyond benefits to Valeant, this will add extra value to the other companies' products that we manufacture here," said Jacques Dessureault, President and General Manager, Valeant Canada. "This technology investment also means consumers can be even more confident in products manufactured by Valeant Canada."
"Valeant Canada plays a vital economic role in Steinbach, Manitoba," said Chris Goertzen, Mayor of Steinbach. "In addition to the 420 employees who go to the facility each day, the facility is a hub of economic activity in the community. We as a city are pleased to see this large and important investment in our growing community."
The implementation of the new quality control technology, upgrades to existing technology and production for new products will take place by the end of 2016.
About Valeant's Steinbach facility
Valeant's largest North American manufacturing site is located in Steinbach, Manitoba, where the company owns and operates a state-of-the-art facility that handles much of Valeant's manufacturing of controlled-release products.
Valeant Canada is a full-service pharmaceutical company engaged in the formulation, clinical testing, registration, manufacturing, sale and promotion of pharmaceutical products utilizing advanced drug-delivery technologies. Each year, the Steinbach facility produces and packages approximately 1.2 billion tablets or capsules of different kinds of medications which are sold worldwide to treat pain, high blood pressure and depression.
With more than 400 employees, Valeant's world-class facility is one of the southeastern Manitoba city's largest employers. The plant currently operates 24-hours, 5 days a week as well as running limited shifts on the weekends.
About Valeant Canada
Valeant Canada is a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products, primarily in the areas of dermatology, eye health, cardio-metabolic, and neurology. More information about Valeant Canada can be found at www.valeantcanada.com.
SOURCE Valeant Canada
Renseignements: Sébastien Beauchamp, Valeant Canada LP, Tel. : 514-744-6792, Courriel : email@example.com